Community site network
The EMS Healthcare model
A flexible community site network built around patients
Most clinical trial networks are built around fixed locations. EMS Healthcare’s community research site network is built around patient populations.
By combining LASER intelligence with over 25 years of community delivery, we place research where participation is realistic, sustainable, and representative, and remain there for the duration of the study.
You don’t need more sites - you need sites in the right places. Introducing, LASER location intelligence...
A flexible community site research network
A site research network designed differently
Fixed sites have fixed reach. When the same locations are used, and the same populations are approached - the same gaps in representation persist.
EMS Healthcare’s community research network enables site and patient access strategies bespoke to your study based on:
- where eligible populations are concentrated
- where participation can be sustained over time
- where underserved populations can be engaged
We identify the right locations first. We then deploy community research sites directly into those environments.
The EMS Healthcare model: built for real-world trial performance
EMS Healthcare combines data-led placement with flexible community delivery. Our model is designed to improve how trials perform in practice. It’s a system built around three things: where patients are, how they live, and what keeps them engaged.
Community-based clinical trial sites
Expanding access to improve clinical trial representation
Improving representation in clinical trials starts with where research is placed.
Traditional clinical trial site networks are often concentrated in established locations, limiting access for patients outside those catchments. As a result, underserved populations - often those with higher disease burden - remain underrepresented in study data.
EMS Healthcare’s community-based clinical trial sites are positioned across the UK using data-driven site selection to extend reach beyond fixed infrastructure, placing research directly within these communities.
By reducing access barriers and enabling participation closer to home, studies can recruit more representative population, resulting in clinical trial data that better reflects real-world use.